• AZ sells respiratory trio to Covis pharmatimes
    November 09, 2018
    Covis currently sells Alvesco, Omnaris and Zetonna in the US and will become the owner of the medicines. In return, it will pay AstraZeneca $350 million upon closing.
PharmaSources Customer Service